: Platelets have a fundamental role in mediating hemostasis and thrombosis. However, more recently, a new idea is making headway, highlighting the importance of platelets as significant actors in modulating immune and inflammatory responses. In particular, platelets have an important role in the development of vascular amyloid-b-peptide(ab) deposits, known to play a relevant role in Alzheimer's disease (AD) through accumulation and deposition within the frontal cortex and hippocampus in the brain. The involvement of platelets in the pathogenesis of AD opens up the highly attractive possibility of applying antiplatelet therapy for the treatment and/or prevention of AD, but conclusive results are scarce. Even less is known about the potential role of platelets in mild cognitive impairment (MCI). The aim to this brief review is to summarize current knowledge on this topic and to introduce the new perspectives on the possible role of platelet activation as therapeutic target both in AD and MCI.
Gallo, A., Lipari, A., Di Francesco, S., Ianuà, E., Liperoti, R., Cipriani, M. C., Martone, A. M., De Candia, E., Landi, F., Montalto, M., Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives, <<INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES>>, 2024; 25 (12): 6292-N/A. [doi:10.3390/ijms25126292] [https://hdl.handle.net/10807/281979]
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives
Gallo, Antonella;Lipari, Alice;Di Francesco, Silvino;Liperoti, Rosa;Cipriani, Maria Camilla;Martone, Anna Maria;De Candia, Erica;Landi, Francesco;Montalto, Massimo
2024
Abstract
: Platelets have a fundamental role in mediating hemostasis and thrombosis. However, more recently, a new idea is making headway, highlighting the importance of platelets as significant actors in modulating immune and inflammatory responses. In particular, platelets have an important role in the development of vascular amyloid-b-peptide(ab) deposits, known to play a relevant role in Alzheimer's disease (AD) through accumulation and deposition within the frontal cortex and hippocampus in the brain. The involvement of platelets in the pathogenesis of AD opens up the highly attractive possibility of applying antiplatelet therapy for the treatment and/or prevention of AD, but conclusive results are scarce. Even less is known about the potential role of platelets in mild cognitive impairment (MCI). The aim to this brief review is to summarize current knowledge on this topic and to introduce the new perspectives on the possible role of platelet activation as therapeutic target both in AD and MCI.File | Dimensione | Formato | |
---|---|---|---|
Platelets_and_Neurodegenerativ.pdf
accesso aperto
Licenza:
Creative commons
Dimensione
290.79 kB
Formato
Adobe PDF
|
290.79 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.